Monocyte Activation Test Market Report 2026

Monocyte Activation Test Market Overview

• Monocyte Activation Test market size has reached to $0.54 billion in 2025 • Expected to grow to $1.08 billion in 2030 at a compound annual growth rate (CAGR) of 14.6% • Growth Driver: Growing Incidence Of Autoimmune Disorders Fueling The Growth Of The Market Due To Rising Immune Dysregulation From Environmental Pollutants • Market Trend: Advancements In Pyrogen And Endotoxin Testing For Enhanced Pharmaceutical Safety • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Monocyte Activation Test Market?

The monocyte activation test (MAT) is an in vitro method used to identify pyrogens by detecting cytokine release, especially interleukin-6 (IL-6), from human monocytes. It mimics the human immune response more closely than traditional animal tests. The main purpose of this test is to ensure pyrogen safety in pharmaceuticals, especially biologics and medical devices. The main product types of the monocyte activation test are reagents, test kits, assay systems, and software solutions. Reagents are specialized chemical or biological substances used to stimulate or detect immune responses, enabling accurate identification of pyrogenic contaminants. It utilizes various technologies such as enzyme-linked immunosorbent assay (ELISA), flow cytometry, polymerase chain reaction (PCR), and Luminex technologies and is distributed through several distribution channels, including direct sales, distributors, or third-party partners, online retailers, and institutional sales. It is applicable for several applications, such as drug development, vaccine development, medical device testing, and others, and is used for various end-users, including pharmaceutical companies, biotechnology companies, research institutions, hospitals, and laboratories.

What Is The Monocyte Activation Test Market Growth Forecast?

The monocyte activation test market size is expected to see rapid growth in the next few years. It will grow to $1.08 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing adoption of advanced biologics and vaccines, rising demand for high-throughput safety testing, expansion of automated laboratory workflows, growing regulatory support for animal-free testing, increasing integration of digital lab platforms. Major trends in the forecast period include increasing adoption of animal-free pyrogen testing, rising use of automated mat assay systems, growing integration of data management software, expansion of gmp-compliant testing solutions, enhanced focus on regulatory acceptance of mat.

Global Monocyte Activation Test Market Segmentation

1) By Product Type: Reagents, Test Kits, Assay Systems, Software Solutions 2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Flow Cytometry, Polymerase Chain Reaction (PCR), Luminex Technologies 3) By Distribution Channel: Direct Sales, Distributors Or Third-party Partners, Online Retailers, Institutional Sales 4) By Application: Drug Development, Vaccine Development, Medical Device Testing, Other Applications 5) By End-User: Pharmaceutical Companies, Biotechnology Companies, Research Institutions, Hospitals And Laboratories Subsegments: 1) By Reagents: Endotoxin Standards, Cytokine Detection Reagents, Cell Culture Media, Limulus Amebocyte Lysate (LAL) Reagents, Blocking Agents And Buffers 2) By Test Kits: Quantitative Monocyte Activation Test Kits, Qualitative Monocyte Activation Test Kits, Good Manufacturing Practice (GMP)-Compliant Test Kits, Endotoxin-Specific Test Kits, Pyrogen Detection Kits 3) By Assay Systems: Benchtop Monocyte Activation Analyzers, Automated High-Throughput Systems, Microplate Readers, Cell Imaging Systems, Flow Cytometry-Based Systems 4) By Software Solutions: Data Analysis Software, Laboratory Information Management Systems (LIMS) Integration Tools, Compliance And Audit Trail Software, Remote Monitoring And Control Software, Real-Time Result Interpretation Tools

What Are The Drivers Of The Monocyte Activation Test Market?

The growing incidence of autoimmune disorders is expected to propel the growth of the monocyte activation test market going forward. Autoimmune disorders are conditions in which the body’s immune system mistakenly attacks its own healthy cells, tissues, or organs instead of protecting the body from infections and foreign substances. The rising prevalence of autoimmune disorders is primarily due to growing exposure to pollutants, which can disrupt immune regulation and trigger abnormal responses. The monocyte activation test (MAT) aids in detecting autoimmune disorders by providing a reliable method for assessing immune system activation. It helps identify abnormal immune responses, crucial for diagnosing conditions such as lupus and rheumatoid arthritis, improving early detection and management of these disorders. For instance, in February 2024, according to the Arthritis Australia, an Australia-based non-profit organization, it is estimated that 562,378 Australians will be living with RA in 2025, accounting for 14% of all arthritis cases that year. By 2040, this number is projected to rise by 33% to 748,721 people. This represents an increase of 186,343 Australians with RA compared with 2025. Therefore, the growing incidence of autoimmune disorders is driving the growth of the monocyte activation test industry. The increasing incidence of healthcare-associated infections is expected to propel the growth of the monocyte activation test market going forward. Healthcare-associated infections are infections that patients acquire while receiving medical care in a healthcare facility. The rise in healthcare-associated infections is driven by increased use of invasive medical devices, which can introduce germs into the body and raise infection risk. The monocyte activation test helps address healthcare-associated infections by detecting pyrogens early, enabling safer medical devices and injectable products that reduce the risk of infection-related complications. For instance, in January 2025, the National Library of Medicine, a US-based organisation collecting and providing access to extensive biomedical literature and data, reported that of 13,654 patients in 218 hospitals, 357 (2.6%) had 392 HAIs. Compared to patients without an HAI, patients with HAIs were more frequently located in large hospitals, in critical care. Therefore, the increasing incidence of healthcare-associated infections is driving the growth of the monocyte activation test industry.

Key Players In The Global Monocyte Activation Test Market

Major companies operating in the monocyte activation test market are Merck KGaA, Becton Dickinson and Company, Eurofins Scientific, Lonza Group, Charles River Laboratories, Nelson Laboratories LLC, Solvias AG, Labor LS SE and Co. KG, BMG Labtech, Cellular Technology Limited, Creative Biolabs, FUJIFILM Wako Chemicals, Microcoat Biotechnologie GmbH, MAT BioTech B.V., Sanquin Diagnostiek B.V., PyroDex LLC, MAT Research B.V., Minerva Biolabs GmbH, Wickham Micro Limited, Rapid Test Methods Ltd.

Global Monocyte Activation Test Market Trends and Insights

Major companies operating in the monocyte activation test market are focused on developing technologically advanced monocyte activation test (MAT) products, such as pyrogen and endotoxin tests, to enhance test sensitivity and improve the detection of immune responses. Pyrogen and endotoxin tests are used to identify substances that induce fever, especially endotoxins from gram-negative bacteria. For instance, in June 2024, FUJIFILM Wako Pure Chemicals Corporation, a Japan-based chemical manufacturer, launched the LumiMAT Pyrogen Detection Kit, a next-generation monocyte activation test for in vitro pyrogen screening, and PYROSTAR Neo+, a recombinant protein reagent for detecting bacterial endotoxins. These products enhance the accuracy, efficiency, and safety of pyrogen testing in the pharmaceutical and biotechnology sectors.

Regional Outlook

North America was the largest region in the monocyte activation test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Monocyte Activation Test Market?

The monocyte activation test market consists of revenues earned by entities by providing services such as pyrogen detection testing, batch release testing, medical device testing, vaccine and biologic testing, and customized test development. The market value includes the value of related goods sold by the service provider or included within the service offering. The monocyte activation test market also includes sales of cryopreserved human monocytes, cytokine detection kits, culture media and buffers, and pyrogen-free consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Monocyte Activation Test Market Report 2026?

The monocyte activation test market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the monocyte activation test industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.